布地奈德混悬液联合异丙托溴铵雾化治疗小儿支气管肺炎的疗效分析.docVIP

布地奈德混悬液联合异丙托溴铵雾化治疗小儿支气管肺炎的疗效分析 　　【摘要】 目的：探讨布地奈德混悬液与异丙托溴铵雾化治疗小儿支气管肺炎的临床疗效。方法：选择笔者所在医院2011年6月-2013年9月收治的100例小儿支气管肺炎患儿为研究对象，按照随机数字表法分为对照组和观察组，每组50例。两组患儿都采取基础治疗，对照组加用布地纳德混悬液行吸入雾化治疗，观察组加用布地纳德与异丙托溴铵雾化治疗，对两组患儿的临床治疗效果进行对比分析。结果：观察组患儿治疗总有效率为90.00%，明显优于对照组的72.00%，两组比较差异有统计学意义（P0.05）。观察组患儿气促、咳嗽、细湿?音等体征消失时间显著短于对照组，两组比较差异有统计学意义（P0.05）。结论：对小儿支气管肺炎采取布地奈德和异丙托溴铵雾化治疗效果显著，安全性高，术后无明显不良反应，值得临床进一步推广使用。 　　【关键词】 布地奈德； 异丙托溴铵； 支气管肺炎 　　中图分类号 R563.1 文献标识码 B 文章编号 1674-6805（2014）26-0059-02 　　【Abstract】 Objective： To investigate the clinical efficacy of budesonide and ipratropium bromide nebulizer treatment of children with bronchial pneumonia.Method： 100 patients with bronchial pneumonia in children in our hospital from June 2011 to September 2013 admitted for the study， were randomly divided into the control group and the observation group， each group of 50 cases.Two group patients have taken the basic treatment， the control group household budesonide inhalation suspension line atomization treatment， observation group were treated with budesonide and ipratropium bromide nebulizer treatment， than the clinical effects were analyzed.Result： The effective rate of the control group was 72.00% while the observation group was 90.00% after treatment， and the difference between the two groups was statistically significant（P0.05）.The shortness of breath， cough， rales disappeared time for clinical treatment of the observation group were significantly less than the control group（P0.05）.Conclusion： Bronchial pneumonia in children taking budesonide and ipratropium bromide nebulizer treatment effect is remarkable， safe， no significant adverse reactions after surgery， worthy of further promotion use. 　　【Key words】 Budesonide； Ipratropium bromide； Bronchial pneumonia 　　First-author’s address： Community Health Service Stations of Heyetang of Hunan Provincial People’s Hospital，Changsha 410000，China 　　小儿支气管肺炎是我国儿科临床常见性疾病，是导致婴幼儿死亡的主要原因。多发于气候骤变、冬春寒冷季节。因患病后，患儿体质较差，免疫力下降，导致易受病菌感染。小儿支气管肺炎主要因细菌或病菌引起。其临床主要表现为咳嗽